Trial Profile
Phase II Study, Evaluation of Low Dose Natural Human Interferon Alpha Administered by the Oral Mucosal Route in the Treatment of Behcet's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2022
Price :
$35
*
At a glance
- Drugs Interferon alpha (Primary)
- Indications Behcet's syndrome; Oral ulcer
- Focus Therapeutic Use
- Sponsors Nobelpharma
- 20 Jul 2011 New trial record